|
Volumn 42, Issue 7, 2002, Pages 680-688
|
Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT1B/1D agonist efficacy in migraine
a b c d e |
Author keywords
Efficacy; Meta analysis; Migraine; Selective 5HT1B 1D agonists
|
Indexed keywords
ALMOTRIPTAN;
FROVATRIPTAN;
NARATRIPTAN;
RIZATRIPTAN;
SEROTONIN 1B AGONIST;
SEROTONIN 1D AGONIST;
SUMATRIPTAN;
ZOLMITRIPTAN;
CALCULATION;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CORRELATION ANALYSIS;
DRUG EFFICACY;
HUMAN;
METHODOLOGY;
MIGRAINE;
PAIN;
PRIORITY JOURNAL;
PUBLISHING;
REVIEW;
SCORING SYSTEM;
STANDARDIZATION;
STATISTICS;
TIME;
ACUTE DISEASE;
CLINICAL TRIALS;
HUMANS;
MIGRAINE DISORDERS;
SEROTONIN AGONISTS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0036656619
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2002.02158.x Document Type: Review |
Times cited : (8)
|
References (19)
|